跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,010 条关于
“HER4”
全部
4,010
临床试验
3,269
药物
289
机构
3
资讯
449
去年
Eribulin-Pyrotinib Combination Shows Promise in Trastuzumab-Resistant HER2+ Breast Cancer
7个月前
NERLYNX Launches in Thailand as New HER2+ Breast Cancer Treatment Option
上个月
Roche Canada and pCPA Complete Negotiations for Perjeta in Neoadjuvant HER2-Positive Early Breast Cancer
9个月前
ArriVent Initiates Pivotal Phase 3 ALPACCA Trial for Firmonertinib in EGFR PACC Mutant NSCLC
上个月
ArriVent Advances Firmonertinib Toward Pivotal EGFR Exon 20 NSCLC Data as ADC Pipeline Progresses
去年
Targeted Therapies and Immunotherapy Advances in Non-Small Cell Lung Cancer: A Comprehensive Review
11个月前
Debiopharm Advances Bispecific ADC Development with SunRock Biopharma's Anti-HER2/HER3 Antibody License
去年
Taiho Pharmaceutical Advances TAS-0728, a Novel HER2/HER3 Inhibitor, for Multiple Solid Tumors
2年前
HER-Vaxx Plus Chemotherapy Shows Survival Benefit in HER2-Overexpressing Gastric Cancer
去年
IBI354 Demonstrates Promising Efficacy and Tolerability in HER2-Positive and HER2-Low Breast Cancer
第 1 页,共 45 页
上一页
下一页